Vol 8, Supplement 3 (November 22, 2019): Translational Lung Cancer Research (Targeted Therapies in NSCLC: An Evolving Landscape)

Editorial

Molecular targeted therapies in non-small cell lung cancer: where we are

Lucio Crinò, Angelo Delmonte

PDF Pages: S222-S223 Full Text (952) Open Access

Original Article

Elemental and mutational analysis of lung tissue in lung adenocarcinoma patients

Ryosuke Chiba, Naoto Morikawa, Koichiro Sera, Kazuyuki Ishida, Hiromi Nagashima, Wataru Shigeeda, Hiroyuki Deguchi, Makoto Tomoyasu, Takako Hosokawa, Hajime Saito, Tamotsu Sugai, Kohei Yamauchi, Makoto Maemondo

PDF Pages: S224-S234 Full Text (1914) Open Access

Review Article

Epidermal growth factor receptor first generation tyrosine-kinase inhibitors

Alex Martinez-Marti, Alejandro Navarro, Enriqueta Felip

PDF Pages: S235-S246 Full Text (2287) Open Access

Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Natalie M. Andrews Wright, Glenwood D. Goss

PDF Pages: S247-S264 Full Text (8980) Open Access

Role of liquid biopsy in oncogene-addicted non-small cell lung cancer

Matteo Canale, Luigi Pasini, Giuseppe Bronte, Angelo Delmonte, Paola Cravero, Lucio Crinò, Paola Ulivi

PDF Pages: S265-S279 Full Text (2511) Open Access

New generation anaplastic lymphoma kinase inhibitors

Angelo Delmonte, Marco Angelo Burgio, Alberto Verlicchi, Giuseppe Bronte, Paola Cravero, Paola Ulivi, Giovanni Martinelli, Lucio Crinò

PDF Pages: S280-S289 Full Text (2840) Open Access

Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer

Fabrizio Tabbò, Silvia Novello

PDF Pages: S290-S297 Full Text (2121) Open Access

Brain metastases in oncogene-driven non-small cell lung cancer

Makoto Nishino, Kenzo Soejima, Tetsuya Mitsudomi

PDF Pages: S298-S307 Full Text (8103) Open Access

Biomarker for personalized immunotherapy

Si-Yang Liu, Yi-Long Wu

PDF Pages: S308-S317 Full Text (2287) Open Access

Editorial Commentary

Tyrosine kinase inhibitors interstitial pneumonitis: diagnosis and management

Yayi He, Caicun Zhou

PDF Pages: S318-S320 Full Text (3418) Open Access

Disclosure:

The supplement “Targeted Therapies in NSCLC: An Evolving Landscape” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Lucio Crinò and Angelo Delmonte served as the unpaid Guest Editors for the supplement.